Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1-Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05419024
What this trial is testing

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption

Who this might be right for
HIV
National Cancer Institute (NCI) 50
Post-approval studies (Phase 4)Ended earlyNCT03532425
What this trial is testing

B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults

Who this might be right for
HIV-1-infection
University of Alberta 28
Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Large-scale testing (Phase 3)UnknownNCT00025727
What this trial is testing

Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure

Who this might be right for
HIV Infections
GlaxoSmithKline 330
Testing effectiveness (Phase 2)Active Not RecruitingNCT07711210
What this trial is testing

Efficacy and Safety of the ACC017-Based Antiretroviral Regimen in Treatment-Experienced Adults With HIV-1 Harboring Non-Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations

Who this might be right for
Infection, Human Immunodeficiency Virus
Jiangsu Aidea Pharmaceutical Group Co., Ltd. 12
Testing effectiveness (Phase 2)Ended earlyNCT00513513
What this trial is testing

TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 7
Early research (Phase 1)Study completedNCT00052182
What this trial is testing

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Very early researchActive Not RecruitingNCT03729778
What this trial is testing

Impact of HIV-1 and Aging on Mucosal Vaccine Responses

Who this might be right for
HIV-1-infectionHuman Immunodeficiency VirusHIV/AIDS+1 more
VA Eastern Colorado Health Care System 100
Large-scale testing (Phase 3)Study completedNCT00543725
What this trial is testing

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Who this might be right for
HIV InfectionsHIV-1
Tibotec Pharmaceuticals, Ireland 680
Not applicableStudy completedNCT01423643
What this trial is testing

HCV/HIV Coinfection: Antiviral Therapy and Fibrosis

Who this might be right for
HIV InfectionHepatitis C
Johns Hopkins University 1,250
Not applicableEnded earlyNCT00340548
What this trial is testing

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Who this might be right for
HemophiliaAIDS
National Cancer Institute (NCI) 333
Not applicableStudy completedNCT01539226
What this trial is testing

Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women

Who this might be right for
HIV Infections
International Partnership for Microbicides, Inc. 1,959
Post-approval studies (Phase 4)Study completedNCT03512210
What this trial is testing

Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection

Who this might be right for
Hepatitis CHIV-1-infectionLiver Diseases
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 400
Not applicableStudy completedNCT03416790
What this trial is testing

IMPAACT 2015 - Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults With Cognitive Impairment

Who this might be right for
HIV-1-infection
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 24
Not applicableStudy completedNCT00346762
What this trial is testing

Evaluating Host and Viral Factors Among HIV Infected Former Commercial Blood Donors in Fuyang, Anhui Province, China

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 186
Early research (Phase 1)Study completedNCT02218125
What this trial is testing

A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected Adults

Who this might be right for
Healthy
Crucell Holland BV 25
Testing effectiveness (Phase 2)Study completedNCT00111280
What this trial is testing

TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial

Who this might be right for
HIV Infection
Tibotec Pharmaceuticals, Ireland 48
Early research (Phase 1)Study completedNCT00002403
What this trial is testing

Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients

Who this might be right for
HIV Infections
Aronex Pharmaceuticals 12
Early research (Phase 1)Study completedNCT00001042
What this trial is testing

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 112
Large-scale testing (Phase 3)WithdrawnNCT00686270
What this trial is testing

A Long Term Safety Study of Apricitabine in HIV-infected Patients

Who this might be right for
HIV Infections
Avexa
Next Page